Rifampin Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Rifampin Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 17, 2021. Reported reason: Other

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-351-20
Dosage Form
Injection
Presentation
Rifampin, Injection, 600 mg (NDC 63323-351-20)
Initial Posting
Feb 17, 2021

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.